Advertisement

Odontopathy and Herbal Medicine

  • Kojiro Yamaguchi
  • Tsuyoshi SugiuraEmail author
Protocol
Part of the Methods in Pharmacology and Toxicology book series (MIPT)

Abstract

This chapter highlights several refractory odontopathies, such as (1) stomatitis, (2) chronic pain [burning mouth syndrome (BMS), glossalgia, atypical facial pain (AFP)], (3) dryness of mouth, (4) taste abnormality, and (5) temporomandibular joint disorder, in which use of Kampo medicines, on the basis of Kampo theory, could exert the maximum effects on human body.
  1. 1.

    In stomatitis, heat may affect the head, chest, and middle abdominal region. Stomatitis is also related to the generation of reactive oxygen species. There are many antioxidants in the crude extracts of Kampo medicines. It is possible to control environmental factors (cold, heat, dampness, dryness) and vital energy, blood, and fluid of the organ systemically using Kampo medicines to treat stomatitis and eliminate local reactive oxygen species accumulation.

     
  2. 2.

    BMS, glossalgia, and AFP are multifactorial syndromes involving the interaction of biological and psychological factors. Local temperature decrease and edema often occur in chronic pain. These are local circulatory disturbances that can be resolved by improving the flow of blood and fluid. Tokishakuyakusan (TSS) and Kamishoyosan (KSS) are effective for enhancing peripheral circulation. Those medicines such as Saikokaryukotuboreito (SRB), Yokukansan (YKS), KSS, and Saibokutou (SBT) can reduce stress. The clinical efficacy of KM for BMS and AFP may depend on the regulation of the mesolimbic dopaminergic and descending glutamatergic pain modulation systems.

     
  3. 3.

    Heat- and cold-dryness stages exist in dry mouth. Byakkokaninjinto is useful for heat-dryness, whereas ninjinyoeito, bakumondoto, and hochuekkito (HET) have moisturizing effects in the cold-dryness stage.

     
  4. 4.

    Taste abnormality: Bitterness is an indicated Syoyobyo stage in the Kampo theory. Saiko-containing formulae are useful for this symptom. Intense sweetness is a sign indicative of digestive canal dampness and heat. Rikkunsito (RKT), Hangeshashinto, etc. are effective for this symptom. The intense astringency can be regarded as a pathological condition of Shoyobyo stage or glossalgia. It is effective to treat with Saiko-containing formulae. Taste loss is a sign of spleen and stomach deficiency. Hozai such as HET, Juzentaihoto, RKT et al. are effective for this symptom.

     
  5. 5.

    Temporomandibular joint disorder: It is usually treated with Shakuyakukanzoto or Kakkonto in the case with myotonia and/or muscle pain. KSS, TSS, and keishibukuryogan are used for blood circulation improvement. KSS, YKS, SRB, SBT, etc. are usually used in the case of psychogenesis.

     

Key words

Kampo therapy Stomatitis Chronic pain Taste abnormality Dry mouth Temporomandibular joint disorder 

References

  1. 1.
    Yamaguchi K (2013) Atypical maxillofacial pain, glossalgia, atypical dental pain. Pain Kampo Med 23:43–47 (in Japanese with English abstract)Google Scholar
  2. 2.
    The Japan Society for Oriental Medicine (2005) Chapter, diagnosis and treatment 22-52: Introduction to Kampo Japanese traditional medicine. Elsevier, TokyoGoogle Scholar
  3. 3.
    Yamaguchi K (2015) Traditional Japanese herbal medicines for treatment of odontopathy. Front Pharmacol Ethnopharmacol 6:1–14Google Scholar
  4. 4.
    Toriizuka K (2003) Monographs of pharmacological research on traditional herbal medicines (Shoyaku no Yakuso·Yakuri). Ishiyaku, Tokyo (in Japanese)Google Scholar
  5. 5.
    Kono T, Satomi M, Chisato N et al (2010) Topical application of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis. World J Oncol 1(6):232–235Google Scholar
  6. 6.
    Okumi H, Koyama A (2014) Kampo medicine for palliative care in Japan. Biopsychosoc Med 8:1–6CrossRefGoogle Scholar
  7. 7.
    Horie N, Hashimoto K, Kato T et al (2008) COX-2 as possible target for the inhibition of PGE2 production by Rikko-san in activated macrophage. In Vivo 22:333–336PubMedGoogle Scholar
  8. 8.
    Zheng LW, Hua H, Cheung LK (2011) Traditional Chinese medicine and oral diseases: today and tomorrow. Oral Dis 17:7–12CrossRefPubMedGoogle Scholar
  9. 9.
    Aoyama T, Nishikawa K, Takiguchi N et al (2014) Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis. Cancer Chemother Pharmacol 73:1047–1054CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Li S, Kodama NE, Inoue Y et al (2010) Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication. Antivir Chem Chemother 20:239–248PubMedGoogle Scholar
  11. 11.
    Dragland S, Senoo H, Wake K et al (2003) Several culinary and medicinal herbs are important sources of dietary antioxidants. J Nutr 133:1286–1290PubMedGoogle Scholar
  12. 12.
    Oka S (1995) The effects of Oren-to on stomatitis. Nihon Toyo Igaku Zasshi 46:439–445 (in Japanese with English abstract)CrossRefGoogle Scholar
  13. 13.
    Hagelberg N, Forssell H, Aalto S et al (2003) Altered dopamine D2 receptor binding in atypical facial pain. Pain 106:43–48CrossRefPubMedGoogle Scholar
  14. 14.
    Hagelberg N, Forssell H, Rinne JO et al (2003) Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 101:149–154CrossRefPubMedGoogle Scholar
  15. 15.
    Hagelberg N, Jȁȁskelȁinen SK, Martikainen IK et al (2004) Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol 500:187–192CrossRefPubMedGoogle Scholar
  16. 16.
    Yilmaz Z, Renton T, Yiangou Y et al (2007) Burning mouth syndrome as a trigeminal small fiber neuropathy: increased heat and capsaicin receptor TRPV1 in nerve fibers correlates with pain score. J Clin Neurosci 14:864–871CrossRefPubMedGoogle Scholar
  17. 17.
    Baker KE, Savage NW (2005) Burning mouth syndrome: an update on recent findings. Aust Dent J 50:220–223CrossRefGoogle Scholar
  18. 18.
    Ferensztajn E, Lojko D, Rybakowski J (2013) Burning mouth syndrome: pathogenic and therapeutic concept. Psychiatr Pol 47:973–988PubMedGoogle Scholar
  19. 19.
    Klasser GD, Epstein JB, Villines D (2011) Management of burning mouth syndrome. J Can Dent Assoc 77:b151PubMedGoogle Scholar
  20. 20.
    Klasser GD, Fischer DJ, Epstein JB (2008) Burning mouth syndrome: recognition, understanding, and management. Oral Maxillofac Surg Clin N Am 20:255–271CrossRefGoogle Scholar
  21. 21.
    Yamaguchi K, Mukai H, Kawashima K et al (2007) Effect of Kampo medicine on the burning mouth syndrome. Pain Kampo Med 17:43–47 (in Japanese with English abstract)Google Scholar
  22. 22.
    Yamaguchi K, Imamura H, Kasuga Y et al (2005) A case report of the burning mouth effectively treated with Byakkokaninjinto (TJ-34). Pain Kampo Med 15:73–76, In JapaneseGoogle Scholar
  23. 23.
    Yamaguchi K, Mukai H, Kawashima K et al (2009) Kikyou-to (TJ138) effective for a case of glossodynia with erythrokeratoderma. Pain Kampo Med 19:66–70Google Scholar
  24. 24.
    Yamaguchi K (2012) Therapy details, oral discomfort. In: Textbook of traditional Japanese medicine. Part 1: Kampo, pp 113–117. Health and Labour Sciences Research Grant: Research on the standardization of traditional Japanese medicine promoting integrated medicineGoogle Scholar
  25. 25.
    Bessho K, Okubo Y, Hori S et al (1998) Effective of Kampo medicine (Sai-boku-to) in treatment of patients with glossodynia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:682–686CrossRefPubMedGoogle Scholar
  26. 26.
    Sasaki K, Suzuki K, Ueno M, Takao K, Yoshizaki F (1998) Increase in monoamine levels caused by emotional stress in mice brain regions is attenuated by Saiko-ka-ryukotsu-borei-to. Methods Find Exp Clin Pharmacol 20:27–30CrossRefPubMedGoogle Scholar
  27. 27.
    Mizoguchi K, Yuzurihara M, Ishige A et al (2003) Saiko-ka-ryukotsu-borei-to, a herbal medicine, ameliorates chronic stress-induced depressive state in rotarod performance. Pharmacol Biochem Behav 75:419–425CrossRefPubMedGoogle Scholar
  28. 28.
    Suzuki Y, Mitsuhata H, Yuzurihara M, Kase Y (2012) Antiallodynic effect of herbal medicine Yokukansan on peripheral neuropathy in rats with chronic constriction injury. Evid Based Complement Alternat Med 2012:1–8CrossRefGoogle Scholar
  29. 29.
    Mizoguchi K, Tanaka Y, Tabira T (2010) Anxiolytic effect of a herbal medicine, yokukansan, in aged rats: involvement of serotonergic and dopaminergic transmissions in the prefrontal cortex. J Ethnopharmacol 127:70–75CrossRefPubMedGoogle Scholar
  30. 30.
    Yanagi Y, Yasuda M, Hashida K et al (2008) Mechanism of salivary secretion enhancement by Byakkokaninjinto. Biol Pharm Bull 31:431–435CrossRefPubMedGoogle Scholar
  31. 31.
    Miyazaki Y, Yamada A, Saitou M (1994) Effect of Ninjin-Youei-tou on xerostomia induced by oxybutynin hydrochloride. Shinyaku to Rinsho 43:2613–2617 (in Japanese)Google Scholar
  32. 32.
    Yamaguchi K, Mukai H, Hamada T, Sugihara K (2012) Three cases report of intraoral discomforts with after cancer treatment successfully treated with Ninjinyoeito (TJ108). Pain Kampo Med 22:56–62 (in Japanese)Google Scholar
  33. 33.
    Nishizawa Y, Nishizawa K, Yoshioka F et al (2002) Long-term effects of traditional Chinese herbal medicine, mai-men-dong-tang (Japanese name: bakumondo-to) compared with bromhexine, hydrochloride on sicca syndrome, especially, salivary secretion in patients with primary Sjögren’s syndrome: a multicenter, randomized well controlled group parallel comparative trial study with bromhexine. Nihon Daekisen Gakkaishi 43:62–66 (in Japanese)Google Scholar
  34. 34.
    Nishizawa Y, Nishizawa K, Yoshioka F et al (2003) Improving effect of Chinese herb medicine mai-men-dong- tang (Japanese name: bakumondo-to) comparative with sicca syndrome in especial salivary patients with secondary Sjögren’s syndrome in multicenter, well controlled, long-term comparative study. Nihon Daekisen Gakkaishi 44:65–70 (in Japanese)Google Scholar
  35. 35.
    Nishizawa Y, Nishizawa K, Yoshioka F et al (2004) Long-term effect of traditional Chinese herbal medicine, mai-men-don-tang on sicca syndrome, especially, salivary secretion in patients with primary Sjögren’s syndrome: a multicenter, randomized well controlled group-parallel double-blinded study. Nihon Daekisen Gakkaishi 45:66–74 (in Japanese)Google Scholar
  36. 36.
    Nishizawa Y, Nishizawa K, Goto GH et al (2004) The multicenter randomized comparative study of kampo herbal medicine, mai-men-dong-tang (Japanese name Bakumondo-to) compared with bromhexine on salivary secretion in secondary Sjögren’s syndrome. Pain Kampo Med 14:10–17 (in Japanese)Google Scholar
  37. 37.
    Ohno S (2006) The effect of Kampo medicine on salivary secretion in Sjögren’s syndrome. Kampo to Saishin-Chiryo 15:134–140 (in Japanese)Google Scholar
  38. 38.
    Wang PL, Sunagawa M, Yamaguchi K et al (2015) EBM of Kampo medicine in oral surgery. Oral Ther Pharmacol 34(1):23–30 (in Japanese)Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Research Field in Dentistry, Medical and Dental Science Area, Research and Education AssemblyKagoshima University Graduate SchoolKagoshimaJapan

Personalised recommendations